6505--CHEYENNE VAMC NUCLEAR MEDICINE RADIOPHARMACEUTICALS

SOL #: 36C25926Q0330Sources Sought

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NETWORK CONTRACT OFFICE 19 (36C259)
Greenwood Village, CO, 80111, United States

Place of Performance

Cheyenne, WY

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 11, 2026
2
Response Deadline
Mar 19, 2026, 6:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the Cheyenne VA Medical Center Diagnostic Imaging (Radiology), has issued a Sources Sought Notice to identify potential sources for Nuclear Medicine Radiopharmaceuticals. This market research aims to procure essential supplies for conducting Nuclear Medicine exams, such as Nuclear Cardiac Stress tests. Responses are due by March 19, 2026, at 12:00 PM Mountain Time.

Scope of Work

The requirement is for a contract to provide nuclear radiopharmaceuticals, which necessitate weekly delivery due to their short half-life and inability to be stored in bulk at the Cheyenne VA Medical Center. The specific type and quantity of radiopharmaceuticals will be determined by physician orders for exams. The Statement of Need outlines a comprehensive list of required items, including but not limited to:

  • Xe133 20mCi Vials
  • Albumin Aggregated (MAA) Kit
  • Mebrofenin (Choletec/Generic) Kits
  • Medronate (MDP) Kit
  • Various Sodium Pertechnetate Tc-99m formulations (Pre-Cal, Act Over Dose Range, Multi-Dose, Non-HEU)
  • I-123 Capsule
  • Mertiatide (MAG-3) Tc-99m Non-HEU
  • Pyrophosphate (PYP) Tc-99m Non-HEU
  • Sestamibi Tc-99m Non-HEU
  • Sulfur Colloid Tc-99m Non-HEU
  • Oxidronate (HDP) Tc-99m Non-HEU (Amyloid)
  • Delivery Charges, Co-57 sheet source, and Survey Meter Calibration.

Contract & Timeline

  • Type: Sources Sought / Market Research
  • Set-Aside: None specified
  • Response Due: March 19, 2026, 12:00 PM Mountain Time (Denver, USA)
  • Published: March 11, 2026
  • Place of Performance: Cheyenne VA Medical Center Diagnostic Imaging (Radiology), 2360 E Pershing Blvd, Cheyenne WY 82001.

Special Requirements

  • A&A (Authorization and Accreditation) requirements do not apply to this request, and a Security Accreditation Package is not required.

Additional Notes

This is a Sources Sought notice for planning purposes only and does not constitute a solicitation. Responses will be used to determine potential sources and inform future procurement strategies. The primary point of contact is Barron Long, Contracting Officer, at barron.long@va.gov or 303-712-5741.

People

Points of Contact

Barron LongContracting OfficerPRIMARY

Files

Files

Download
Download

Versions

Version 1Viewing
Sources Sought
Posted: Mar 11, 2026
6505--CHEYENNE VAMC NUCLEAR MEDICINE RADIOPHARMACEUTICALS | GovScope